| Primary |
| Hyperthyroidism |
31.9% |
| Basedow's Disease |
26.4% |
| Schizophrenia |
11.1% |
| Hypertension |
9.7% |
| Asthma |
5.6% |
| Diabetes Mellitus |
5.6% |
| Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis |
2.8% |
| Osteoporosis |
2.8% |
| Parkinson's Disease |
2.8% |
| Dermatitis Allergic |
1.4% |
|
| Foetal Exposure During Pregnancy |
13.8% |
| Vitello-intestinal Duct Remnant |
10.3% |
| Hepatic Necrosis |
6.9% |
| Pancreatitis Acute |
6.9% |
| Tooth Abscess |
6.9% |
| White Blood Cell Count Decreased |
6.9% |
| Abortion Late |
3.4% |
| Acute Generalised Exanthematous Pustulosis |
3.4% |
| Cholestasis |
3.4% |
| Drug-induced Liver Injury |
3.4% |
| Exposure During Pregnancy |
3.4% |
| Hypoglycaemia |
3.4% |
| Hypothyroidism |
3.4% |
| Micrococcus Infection |
3.4% |
| Multi-organ Failure |
3.4% |
| Myositis |
3.4% |
| Psychotic Disorder |
3.4% |
| Pulmonary Alveolar Haemorrhage |
3.4% |
| Pyrexia |
3.4% |
| Renal Failure Chronic |
3.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.4% |
| Hyperthyroidism |
14.1% |
| Product Used For Unknown Indication |
9.4% |
| Hiv Infection |
9.0% |
| Essential Hypertension |
5.1% |
| Sleep Disorder |
5.1% |
| Thrombosis Prophylaxis |
5.1% |
| Hyperuricaemia |
4.3% |
| Diabetes Mellitus |
3.8% |
| Fluid Replacement |
3.4% |
| Hypertension |
3.4% |
| Hypokalaemia |
3.4% |
| Antifungal Prophylaxis |
2.6% |
| Polyuria |
2.6% |
| Acute Myocardial Infarction |
1.7% |
| Agitation |
1.7% |
| Basedow's Disease |
1.7% |
| Cardiac Failure |
1.7% |
| Diarrhoea |
1.7% |
| Hypercholesterolaemia |
1.7% |
|
| Platelet Count Decreased |
18.8% |
| Swollen Tongue |
12.5% |
| Hepatic Necrosis |
6.3% |
| Hepatocellular Damage |
6.3% |
| Hyperthyroidism |
6.3% |
| Polyneuropathy |
6.3% |
| Hepatitis Acute |
3.1% |
| Hypothyroidism |
3.1% |
| Iron Deficiency |
3.1% |
| Muscle Spasms |
3.1% |
| Neutropenia |
3.1% |
| Off Label Use |
3.1% |
| Polyarthritis |
3.1% |
| Psychotic Disorder |
3.1% |
| Rash |
3.1% |
| Sepsis |
3.1% |
| Tonsillitis Streptococcal |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Tricuspid Valve Incompetence |
3.1% |
| Urticaria |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.6% |
| Hyperthyroidism |
10.3% |
| Rheumatoid Arthritis |
8.2% |
| Hypertension |
7.1% |
| Product Used For Unknown Indication |
6.3% |
| Cardiac Failure |
5.3% |
| Chronic Obstructive Pulmonary Disease |
4.7% |
| Depression |
4.7% |
| Hiv Infection |
4.7% |
| Atrial Fibrillation |
4.5% |
| Prophylaxis |
4.5% |
| Coronary Artery Disease |
4.0% |
| Mycobacterium Avium Complex Infection |
3.2% |
| Type 2 Diabetes Mellitus |
2.6% |
| Non-small Cell Lung Cancer |
2.4% |
| Thyroid Storm |
2.4% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Hypercholesterolaemia |
2.1% |
| Hyperparathyroidism Secondary |
2.1% |
| Hypothyroidism |
2.1% |
|
| Acoustic Neuroma |
8.3% |
| Hypotension |
8.3% |
| General Physical Health Deterioration |
6.7% |
| Vomiting |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| Drug Interaction |
5.0% |
| Gastrointestinal Haemorrhage |
5.0% |
| Jaundice |
5.0% |
| Malignant Neoplasm Progression |
5.0% |
| Renal Failure Acute |
5.0% |
| Renal Infarct |
5.0% |
| Torsade De Pointes |
5.0% |
| Weight Increased |
5.0% |
| Bronchitis |
3.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.3% |
| Hyperthyroidism |
3.3% |
| Laceration |
3.3% |
| Nausea |
3.3% |
| Pneumonia |
3.3% |
| Pregnancy Induced Hypertension |
3.3% |
|
| Interacting |
|
|
